Published on : Apr 23, 2018
Albany, New York, April 23, 2018: A novel research publication reflects the current market scenario as well as future prospects of the global non-opioid pain treatment industry. This analytical research study has been included in the extensive research repository of MRH (Market Research Hub). Significant aspects related to the growth path of the market along with future projections for a period of four years, from 2018 till 2022, have been included in the research report named “Global Non-opioid Pain Treatment Industry 2018, Trends and Forecast Report”, in a systematic manner along with incisive insights.
The management of acute and chronic pain often includes opioid therapy. However, opioid medications also carry a risk of abuse or addiction by either the patient or non-medical users. For these reasons, consideration of non-opioid strategies for pain management is favorable. It has been analyzed that there are many non-opioid pain medications that are available over-the-counter or by prescription, such as ibuprofen (Motrin), acetaminophen (Tylenol), aspirin (Bayer) and steroids, and some patients find that these are all they need. As per the findings, rising geriatric population across the globe who are prone to various types of chronic as well as acute pain are contributing towards the rising demand for non-opioid pain treatment. Consequently, the global market for non-opioid pain treatment estimated to grow at a steady pace until the end of 2022.
Geographically, this research report is based on condition of globe’s significant regional markets. The regions covered in this report are Asia Pacific, North America and Europe, while key countries covered in this report are China, United States, South Korea, Germany, Japan, and United Kingdom. Additionally, he report examines the market with a ground-up approach, beginning with details regarding industry specific definitions of non-opioid pain treatment, major product types in the market and key application areas. Major treatment type in non-opioid treatment include Medical cannabis treatments, Omega 3 fatty acid-containing treatments, Botulinum toxins, Capsaicin-derived treatments and Menthol-containing treatments.
Further, qualitative and quantitative data pertaining to specifics such as the industry chain, industry development over the study’s review period, forecast pertaining to market’s future developmental prospects, and import and export scenario have also been included in the report. A competitive landscape that profiles some of the leading players in the market has also been analyzed in detail in the report. The detailed competitive profiling can help stakeholders in making critical decisions on the basis of accurate information. Readers will also gain information on market entry strategies and lucrative marketing channels prevalent in the landscape.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1711060
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org